Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSUNC7467 is an inhibitor of inositol hexakisphosphate kinase 1 (IP6K1) and IP6K2 (IC50s = 8.9 and 4.9 nM, respectively).1 It is selective for IP6K1 and IP6K2 over IP6K3 and inositol-triphosphate 3-kinase A (ITPKA; IC50s = 1,320 and 832 nM, respectively), as well as a panel of 30 other kinases at 1 µM, but does inhibit inositol phosphate multi-kinase (IPMK; IC50 = 24.4 nM). In vivo, UNC7467 (5 mg/kg per day) reduces body weight, fat mass, epididymal- and inguinal-adipose tissue deposit weights, and liver weight, as well as blood glucose levels in a pyruvate tolerance test after four weeks, in a mouse model of diet-induced obesity.
WARNING This product is not for human or veterinary use.
1. Development of novel IP6K inhibitors for the treatment of obesity and obesity-